Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 7/2016

01-07-2016 | Original Article

Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India

Authors: Soumee Ghosh, Sudakshina Ghosh, Biswabandhu Bankura, Makhan Lal Saha, Suvendu Maji, Souvik Ghatak, Arup Kumar Pattanayak, Susanta Sadhukhan, Manalee Guha, Senthil Kumar Nachimuthu, Chinmay Kumar Panda, Biswanath Maity, Madhusudan Das

Published in: Tumor Biology | Issue 7/2016

Login to get access

Abstract

Gastric cancer is one of the most common malignancies in India. DNA repair gene or xenobiotic pathway gene polymorphisms have recently been shown to affect individual susceptibility to gastric cancer. Here, the possible interaction between common polymorphisms in X-ray repair cross complementing group I (XRCC1) gene and glutathione S-transferase (GST) genes (GSTM1, GSTT1 and GSTP1), smoking and alcohol consumption and overall survival in gastric cancer patients were evaluated. In this population-based case control study, 70 gastric cancer patients and 82 healthy controls were enrolled. The epidemiological data were collected by a standard questionnaire, and blood samples were collected from each individual. XRCC1 Arg194Trp, Arg280His and Arg399Gln polymorphisms were determined by polymerase chain reaction and direct DNA sequencing. GSTM1 and GSTT1 null polymorphisms and GSTP1 Ile105Val polymorphism were identified by multiplex polymerase chain reaction and restriction fragment length polymorphism (RFLP), respectively. The risk of gastric cancer was significantly elevated in individuals with XRCC1 Arg/Gln +Gln/Gln (p = 0.031; odds ratio = 2.32; 95 % confidence interval (CI) 1.07–5.06) and GSTP1 Val/Val genotype (p = 0.009; odds ratio = 8.64; 95 % CI 1.84–40.55). An elevated risk for GC was observed in smokers and alcohol consumers carrying GSTP1 Ile/Val +Val/Val genotype (p = 0.041; odds ratio = 3.71; 95 % CI 0.98–14.12; p = 0.002; odds ratio = 12.31; 95 % CI 1.71–88.59). These findings suggest that XRCC1 rs25487 and GSTP1 rs1695 can be considered as a risk factor associated with gastric cancer and might be used as a molecular marker for evaluating the susceptibility of the disease.
Appendix
Available only for authorised users
Literature
1.
Stewart BW, Wild CP, editors. World cancer report. Lyon: IARC; 2014.
2.
Takiar R, Nadayil D, Nandakumar A. Projections of number of cancer cases in India (2010–2020) by cancer groups. Asian Pac J Cancer Prev. 2010;11:1045–9.PubMed
3.
Zhao Y, Deng X, Song G, Qin S, Liu Z. The GSTM1 null genotype increased risk of gastric cancer: a meta-analysis based on 46 studies. PLoS One. 2013;8, e81403.CrossRefPubMedPubMedCentral
4.
5.
Liu BM, Liu TM, You BS, You HY, Yang J, Li L, et al. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis. Genet Mol Res. 2012;11:3852–60.CrossRefPubMed
6.
Palli D, Polidoro S, D’Errico M, Saieva C, Guarrera S, Calcagnile AS, et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis. 2010;25:569–75.CrossRefPubMed
7.
Yuan T, Deng S, Chen M, Chen W, Lu W, Huang H, et al. Association of DNA repair gene XRCC1 and XPD polymorphisms with genetic susceptibility to gastric cancer in a Chinese population. Cancer Epidemiol. 2011;35:170–4.CrossRefPubMed
8.
Marintchev A, Mullen MA, Maciejewski MW, Pan B, Gryk MR, Mullen GP. Solution structure of the single-strand break repair protein XRCC1 N-terminal domain. Nat Struct Biol. 1999;6:884–93.CrossRefPubMed
9.
Qiao W, Wang T, Zhang L, Tang Q, Wang D, Sun H. Association study of single nucleotide polymorphisms in XRCC1 gene with the risk of gastric cancer in Chinese population. Int J Biol Sci. 2013;9:753–8.CrossRefPubMedPubMedCentral
10.
Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, et al. Effect of genetic polymorphisms related to DNA repair and the xenobiotic pathway on the prognosis and survival of gastric cancer patients. Anticancer Res. 2011;31:705–10.PubMed
11.
García-González MA, Quintero E, Bujanda L, Nicolás D, Benito R, Strunk M, et al. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype. Mutagenesis. 2012;27:771–7.CrossRefPubMed
12.
Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300(Pt 1):271–6.CrossRefPubMedPubMedCentral
13.
Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600.CrossRefPubMed
14.
Malik MA, Upadhyay R, Mittal RD, Zargar SA, Modi DR, Mittal B. Role of xenobiotic-metabolizing enzyme gene polymorphisms and interactions with environmental factors in susceptibility to gastric cancer in Kashmir valley. J Gastrointest Cancer. 2009;40:26–32.CrossRefPubMed
15.
Yadav DS, Devi TR, Ihsan R, Mishra AK, Kaushal M, Chauhan PS, et al. Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population. Genet Test Mol Biomarkers. 2010;14:715–23.CrossRefPubMed
16.
Tripathi S, Ghoshal U, Mittal B, Chourasia D, Kumar S, Ghoshal UC. Association between gastric mucosal glutathione-S-transferase activity, glutathione-S-transferase gene polymorphisms and Helicobacter pylori infection in gastric cancer. Indian J Gastroenterol. 2011;30:257–63.CrossRefPubMed
17.
Khabaz MN. Polymorphism of the glutathione S-transferase P1 gene (GST-PI) in breast carcinoma. Pol J Pathol. 2014;65:141–6.CrossRefPubMed
18.
Furberg AH, Ambrosone CB. Molecular epidemiology, biomarkers and cancer prevention. Trends Mol Med. 2001;7:517–21.CrossRefPubMed
19.
Schneider J, Classen V, Helmig S. XRCC1 polymorphism and lung cancer risk. Expert Rev Mol Diagn. 2008;8:761–80.CrossRefPubMed
20.
Lee S-G, Kim B, Choi J, Kim C, Lee I, Song K. Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett. 2002;187:53–60.CrossRefPubMed
21.
Shen H, Xu Y, Qian Y, Yu R, Qin Y, Zhou L, et al. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer. 2000;88:601–6.CrossRefPubMed
22.
Piao JM, Shin MH, Kweon SS, Kim HN, Choi JS, Bae WK, et al. Glutathione-S-transferase (GSTM1, GSTT1) and the risk of gastrointestinal cancer in a Korean population. World J Gastroenterol. 2009;15:5716–21.CrossRefPubMedPubMedCentral
23.
Zhang Y, Sun L-P, Xing C-Z, Xu Q, He C-Y, Li P, et al. Interaction between GSTP1 Val Allele and H. pylori infection, smoking and alcohol consumption and risk of gastric cancer among the Chinese population. Guan X-Y, editor. PLoS One. 2012; e47178.
24.
Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, et al. Association between genetic polymorphisms related to DNA repair or xenobiotic pathways and gastric premalignant conditions. Anticancer Res. 2011;31:1459–65.PubMed
25.
Goekkurt E, Al-Batran S-E, Hartmann JT, Mogck U, Schuch G, Kramer M, et al. Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie. J Clin Oncol. 2009;27:2863–73.CrossRefPubMed
26.
Shim HJ, Yun JY, Hwang JE, Bae WK, Cho SH, Lee JH, et al. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin. Cancer Sci. 2010;101:1247–54.CrossRefPubMed
27.
Tripathi S, Ghoshal U, Ghoshal UC, Mittal B, Krishnani N, Chourasia D, et al. Gastric carcinogenesis: possible role of polymorphisms of GSTM1, GSTT1, and GSTP1 genes. Scand J Gastroenterol. 2008;43:431–9.CrossRefPubMed
28.
Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.PubMed
29.
González JR, Armengol L, Solé X, Guinó E, Mercader JM, Estivill X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics. 2007;23:644–5.PubMed
30.
National Family Health Survey (NFHS-3). 2005–06: India: volume I. Int. Inst. Popul. Sci. Macro Int. Mumbai; 2007.
31.
Rannala B. Finding genes influencing susceptibility to complex diseases in the post-genome era. Am J Pharmacogenomics. 2001;1:203–21.CrossRefPubMed
32.
Ratnasinghe LD, Abnet C, Qiao Y-L, Modali R, Stolzenberg-Solomon R, Dong Z-W, et al. Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett. 2004;216:157–64.CrossRefPubMed
33.
Jin E-H, Kim J, Lee S-I, Hong JH. Association between polymorphisms in APE1 and XRCC1 and the risk of gastric cancer in Korean population. Int J Clin Exp Med. 2015;8:11484–9.PubMedPubMedCentral
34.
Yan L, Yanan D, Donglan S, Na W, Rongmiao Z, Zhifeng C. Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma. Dis Esophagus. 2009;22:396–401.CrossRefPubMed
35.
Xue H, Ni P, Lin B, Xu H, Huang G. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: a HuGE review and meta-analysis. Am J Epidemiol. 2011;173:363–75.CrossRefPubMed
36.
Duarte MC, Colombo J, Rossit ARB, Caetano A, Borim AA, Wornrath D, et al. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol. 2005;11:6593–600.CrossRefPubMedPubMedCentral
37.
Pan X-F, Xie Y, Loh M, Yang S-J, Wen Y-Y, Tian Z, et al. Polymorphisms of XRCC1 and ADPRT genes and risk of noncardia gastric cancer in a Chinese population: a case–control study. Asian Pac J Cancer Prev. 2012;13:5637–42.CrossRefPubMed
38.
Wen Y-Y, Pan X-F, Loh M, Tian Z, Yang S-J, Lv S-H, et al. ADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China. Asian Pac J Cancer Prev. 2012;13:2139–44.CrossRefPubMed
39.
Zhao D-Y, Cheng L, Yu J, Shen H. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision. Cancer Biomark. 2014;14:449–56.CrossRefPubMed
40.
Feng Y-Z, Liu Y-L, He X-F, Wei W, Shen X-L, Xie D-L. Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case–control studies. Tumour Biol. 2014;35:10677–97.CrossRefPubMed
41.
Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J, de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998;18:3563–71.CrossRefPubMedPubMedCentral
42.
Callebaut I, Mornon JP. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 1997;400:25–30.CrossRefPubMed
43.
Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis. 2000;21:965–71.CrossRefPubMed
44.
Zhang ZY, Xuan Y, Jin XY, Tian X, Wu R. Meta-analysis demonstrates association of XRCC1 genetic polymorphism Arg399Gln with esophageal cancer risk in the Chinese population. Genet Mol Res. 2013;12:2567–77.CrossRefPubMed
45.
Wu K, Su D, Lin K, Luo J, Au WW. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case–control studies. Asian Pac J Cancer Prev. 2011;12:2237–43.PubMed
46.
Yan J, Wang X, Tao H, Deng Z, Yang W, Lin F. Meta-analysis of the relationship between XRCC1-Arg399Gln and Arg280His polymorphisms and the risk of prostate cancer. Sci Rep. 2015;5:9905.CrossRefPubMedPubMedCentral
47.
Forat-Yazdi M, Gholi-Nataj M, Neamatzadeh H, Nourbakhsh P, Shaker-Ardakani H. Association of XRCC1 Arg399Gln polymorphism with colorectal cancer risk: a HuGE meta analysis of 35 studies. Asian Pac J Cancer Prev. 2015;16:3285–91.CrossRefPubMed
48.
Chen L, Zhuo D, Chen J, Yuan H. XRCC1 polymorphisms and lung cancer risk in Caucasian populations: a meta-analysis. Int J Clin Exp Med. 2015;8:14969–76.PubMedPubMedCentral
49.
Qi Y, Cui L, Song Y, Li N. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis. Mol Biol Rep. 2014;41:879–87.CrossRefPubMed
50.
Engin AB, Karahalil B, Karakaya AE, Engin A. Association between XRCC1 ARG399GLN and P53 ARG72PRO polymorphisms and the risk of gastric and colorectal cancer in Turkish population. Arh Hig Rada Toksikol. 2011;62:207–14.CrossRefPubMed
51.
Capellá G, Pera G, Sala N, Agudo A, Rico F, Del Giudicce G, et al. DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol. 2008;37:1316–25.CrossRefPubMed
52.
Yi L, Xiao-Feng H, Yun-Tao L, Hao L, Ye S, Song-Tao Q. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case–control studies. PLoS One. Public Library of Science; 2013;8:e78071.
53.
Natukula K, Jamil K, Pingali UR, Suresh Attili VS, Naidu Madireddy UR, Attili VSS, et al. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians. Asian Pac J Cancer Prev. 2013;14:5275–9.CrossRefPubMed
54.
Nissar S, Lone TA, Banday MZ, Rasool R, Chowdri NA, Parray FQ, et al. Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: a case control study. Oncol Lett. 2013;5:959–63.PubMedPubMedCentral
55.
Saikia BJ, Phukan RK, Sharma SK, Sekhon SK, Mahanta J. Interaction of XRCC1 and XPD gene polymorphisms with lifestyle and environmental factors regarding susceptibility to lung cancer in a high incidence population in North East India. Asian Pac J Cancer Prev. 2014;15:1993–9.CrossRefPubMed
56.
Langsenlehner T, Renner W, Gerger A, Hofmann G, Thurner EM, Kapp KS, et al. Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients. Radiother Oncol. 2011;98:387–93.CrossRefPubMed
57.
Hoyos-Giraldo LS, Carvajal S, Cajas-Salazar N, Ruíz M, Sánchez-Gómez A. Chromosome aberrations in workers exposed to organic solvents: influence of polymorphisms in xenobiotic-metabolism and DNA repair genes. Mutat Res Fundam Mol Mech Mutagen. 2009;666:8–15.CrossRef
58.
Hung RJ, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst. 2005;97:567–76.CrossRefPubMed
59.
Hong YC, Lee KH, Kim WC, Choi SK, Woo ZH, Shin SK, et al. Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer. Int J Cancer. 2005;116:428–32.CrossRefPubMed
60.
Saadat M. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci. 2006;97:505–9.CrossRefPubMed
61.
Boccia S, La Torre G, Gianfagna F, Mannocci A, Ricciardi G. Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis. 2006;21:115–23.CrossRefPubMed
62.
63.
Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, et al. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev. 2007;31:233–6.CrossRefPubMedPubMedCentral
64.
Chen B, Cao L, Zhou Y, Yang P, Wan H-W, Jia G-Q, et al. Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiologic studies. Dig Dis Sci. 2010;55:1831–8.CrossRefPubMed
65.
Dunna NR, Vuree S, Kagita S, Surekha D, Digumarti R, Rajappa S, et al. Association of GSTP1 gene (I105V) polymorphism with acute leukaemia. J Genet. 2012;91:1–4.CrossRef
66.
Srivastava DSL, Mandhani A, Mittal B, Mittal RD. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int. 2005;95:170–3.CrossRefPubMed
67.
Maggini V, Buda G, Galimberti S, Martino A, Orciuolo E, Morabito F, et al. Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk. Leuk Res. 2008;32:988–90.CrossRefPubMed
68.
Bao LD, Niu JX, Song H, Wang Y, Ma RL, Ren XH, et al. Association between the GSTP1 codon 105 polymorphism and gastric cancer risk: an updated meta-analysis. Asian Pac J Cancer Prev. 2012;13:3687–93.CrossRefPubMed
69.
Sreeja L, Syamala V, Hariharan S, Syamala VS, Raveendran PB, Sivanandan CD, et al. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients. J Exp Ther Oncol. 2008;7:73–85.PubMed
Metadata
Title
Association of DNA repair and xenobiotic pathway gene polymorphisms with genetic susceptibility to gastric cancer patients in West Bengal, India
Authors
Soumee Ghosh
Sudakshina Ghosh
Biswabandhu Bankura
Makhan Lal Saha
Suvendu Maji
Souvik Ghatak
Arup Kumar Pattanayak
Susanta Sadhukhan
Manalee Guha
Senthil Kumar Nachimuthu
Chinmay Kumar Panda
Biswanath Maity
Madhusudan Das
Publication date
01-07-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 7/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4780-5

Other articles of this Issue 7/2016

Tumor Biology 7/2016 Go to the issue

Original Article

Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma

Original Article

Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer

Original Article

Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population

Original Article

Expression and prognostic value of miR-92a in patients with gastric cancer

Original Article

Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells

Original Article

The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits